Evidence map›Paper›PMID 33014822›Full record

ArticleFrontiers in oncology2020

Diagnostic Accuracy and Safety of Coaxial System in Oncology Patients Treated in a Specialist Cancer Center With Prospective Validation Within Clinical Trial Data.

Khurum Khan, Reyes Gonzalez-Exposito, David Cunningham, Dow-Mu Koh, Andrew Woolston, Louise Barber, Beatrice Griffiths, Kyriakos Kouvelakis, Vanessa Calamai, Monia Bali and 13 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 1 country.

Khurum KhanDepartment of Gastrointestinal Oncology, UCL Cancer Institute, University College NHS Foundation Trust, London, United Kingdom.
Reyes Gonzalez-ExpositoDepartment of Medicine, The Royal Marsden NHS Trust, London, United Kingdom.
David CunninghamDepartment of Medicine, The Royal Marsden NHS Trust, London, United Kingdom.
Dow-Mu KohCancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom.
Andrew WoolstonTranslational Oncogenomics Laboratory, Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.
Louise BarberTranslational Oncogenomics Laboratory, Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.
Beatrice GriffithsTranslational Oncogenomics Laboratory, Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.
Kyriakos KouvelakisDepartment of Medicine, The Royal Marsden NHS Trust, London, United Kingdom.
Vanessa CalamaiDepartment of Medicine, The Royal Marsden NHS Trust, London, United Kingdom.
Monia BaliCancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom.
Nasir KhanCancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom.
Annette BryantDepartment of Medicine, The Royal Marsden NHS Trust, London, United Kingdom.
Claire SafferyDepartment of Medicine, The Royal Marsden NHS Trust, London, United Kingdom.
Charles DearmanDepartment of Medicine, The Royal Marsden NHS Trust, London, United Kingdom.
Ruwaida BegumDepartment of Medicine, The Royal Marsden NHS Trust, London, United Kingdom.
Sheela RaoDepartment of Medicine, The Royal Marsden NHS Trust, London, United Kingdom.
Naureen StarlingDepartment of Medicine, The Royal Marsden NHS Trust, London, United Kingdom.
David WatkinsDepartment of Medicine, The Royal Marsden NHS Trust, London, United Kingdom.
Ian ChauDepartment of Medicine, The Royal Marsden NHS Trust, London, United Kingdom.
Chiara BraconiDepartment of Medicine, The Royal Marsden NHS Trust, London, United Kingdom.
Nicola ValeriDepartment of Medicine, The Royal Marsden NHS Trust, London, United Kingdom.
Marco GerlingerDepartment of Medicine, The Royal Marsden NHS Trust, London, United Kingdom.
Nicos FotiadisCancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom.
Institute of Cancer Research · GBRoyal Marsden Hospital · GBCancer Research UK · GBUniversity College London · GB

Funding

Cancer Research UK 18052
6 · The paper itself

Abstract

backgroundImage-guided tissue biopsies are critically important in the diagnosis and management of cancer patients. High-yield samples are also vital for biomarker and resistance mechanism discovery through molecular/genomic analyses. PATIENTS AND

methodsAll consecutive patients who underwent plugged image-guided biopsy at Royal Marsden from June 2013 until September 2016 were included in the analysis. In the next step, a second cohort of patients prospectively treated within two clinical trials (PROSPECT-C and PROSPECT-R) were assessed for the DNA yield from biopsies assessed for complex genomic analysis.

resultsA total of 522 plugged core biopsies were performed in 457 patients [men, 52%; median age, 63 years (range, 17-93)]. Histological diagnosis was achieved in 501 of 522 (96%) performed biopsies. Age, gender, modality, metastatic site, and seniority of the interventionist were not found to be significant factors associated with odds of failure on a logistic regression. Seventeen (3.3%) were admitted due to biopsy-related complications; nine, three, two, one, one, and one were admitted for grade I/II pain control, sepsis, vasovagal syncope, thrombosis, hematuria, and deranged liver functions, respectively; two patients with right upper quadrant pain after liver biopsy were found to have radiologically confirmed subcapsular hematoma requiring conservative treatment. One patient (0.2%) developed grade III hemorrhage following biopsy of a gastric gastrointestinal stromal tumor (GIST). Overall molecular analysis was successful in 89% (197/222 biopsies). Prospective validation in 62 biopsies gave success rates of 92.06 and 79.03% for DNA extraction of >1 μm and tmour content of >20%, respectively.

conclusionThe probability of diagnostic success for complex molecular analysis is increased with plugged large coaxial needle biopsy technique, which also minimizes complications and reduces hospital stay. High-yield DNA acquisition allows genomic molecular characterization for personalized medicine.

Indexed as

clinical trialscoaxial core-needle biopsy systemformalin-fixed paraffin-embeddedgenomic analysistissue biopsies

Identifiers

PMID33014822
PMCPMC7500492
OpenAlexW3083418665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.